About Lundbeck India Private Limited
Data last updated:
Lundbeck India Private Limited is a private limited company based in Bangalore, Karnataka, India, a subsidiary of H Lundbeck A/S., Denmakr. The company is currently under liquidation, meaning its assets are being sold to settle outstanding debts. It may not have the legal capacity to fulfil new contracts. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 January 2002.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24231KA2002PTC029998. Its GSTIN is 29AAACL6925E1ZH (Karnataka). The company holds 10 GST registrations, of which 9 are active.
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹5 Cr. It is led by directors Morten Bryde Hansen and Riyan Ahmed Khan.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Bangalore, Karnataka.
As per the financials filed for FY 2023, the company reported a revenue of ₹1.23 Cr, a decline of 91% compared to the previous year. For the same year it recorded a net profit of ₹48.44 Lakh (net margin 39.5%) and EBITDA of ₹52.74 Lakh (EBITDA margin 43%). Revenue has declined at a compounded annual rate (CAGR) of 62% over three years and 38% over five years.
The company has about 2 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Lundbeck. Court records list 32 cases involving the company, including 25 filed by the company and 7 filed against it; 3 cases are pending.
The last known website on record is lundbeck.com.
Company details
Contact details
Lundbeck India Private Limited's registered office is in Bangalore, Karnataka. Its website is lundbeck.com. Its e-mail address is in the company report.
- Email
- Website
- Social Media
- Registered Address4C – 515/40 4th Cross Hrbr Layout, Banasavadi, Bangalore, Karnataka, India – 560043
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Lundbeck India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Lundbeck India operates one associated brand: Lundbeck. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Drugs for CNS disorders are developed and advanced. | lundbeck.com |
Business activity
The main business activity of Lundbeck India is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Lundbeck India Private Limited, buy the company report.
Financials of Lundbeck India Private Limited
FY 2023 filings availableLundbeck India Private Limited reported revenue of ₹1.23 Cr (down 91% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 38% over five years, including a 91% fall in the latest year. EBITDA rose 133% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹52.74 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹48.44 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 43% | ||||
| Net Profit Margin | 39.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Lundbeck India Private Limited, buy the company report.
Board of directors of Lundbeck India Private Limited
Lundbeck India has 2 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Morten Bryde Hansen | Director | 05 Jan 2004 | 22 Years 9 Months | As last reported |
| Riyan Ahmed Khan | Director | 11 Sep 2023 | 3 Years 1 Months | As last reported |
Peer comparison
Lundbeck India Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| 3C Pharmaceuticals Private Limited | ₹1.24 Cr (FY 2019) | 264.0% | Hyderabad, Telangana, India | |||
| Span Generics Private Limited | ₹1.23 Cr (FY 2023) | 51826.0% | New Delhi, Delhi, India | |||
| Lundbeck India Private Limitedthis company | ₹1.23 Cr (FY 2023) | ₹48.44 Lakh | 39.5% | -91.0% | 2 | Bangalore, Karnataka, India |
| Getwell Nutraceuticals India Private Limited | ₹1.23 Cr (FY 2018) | 34.0% | Patna, Bihar, India |
To see the full peer comparison of Lundbeck India Private Limited, buy the company report.
Auditor
Lundbeck India Private Limited is audited by Price Waterhouse Chartered Accountants LLP for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Price Waterhouse Chartered Accountants LLP | FY 2021 | 012754N/N500016 |
Shareholding
The shareholding of Lundbeck India Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Lundbeck India Private Limited, buy the company report.
Legal cases
Lundbeck India Private Limited has 32 court cases on record: 25 filed by Lundbeck India, 7 filed against it. 3 cases are pending and 29 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 17 | 4 | 3 |
| High courts | 15 | 3 | 0 |
Cases on record (5 of 32)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, North Goa, Goa | Court case (SCS) | Filed against the company by CFL Pharmaceuticals Ltd. | Disposed |
| District court, Calcutta, West Bengal | Civil suit | Filed by the company against Life Medical Agency Pvt. Ltd. and 2 others | Disposed |
| District court, BENGALURU, Karnataka | Civil suit | Filed by the company against The Indian Express Ltd. and 9 others | Disposed |
| District court, Calcutta, West Bengal | Civil suit | Filed by the company against an individual | Pending |
| District court, Calcutta, West Bengal | Civil suit | Filed by the company against an individual | Pending |
To see the full case history of Lundbeck India Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Lundbeck India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Lundbeck India Private Limited has a workforce of 2 employees on its EPFO records as of Apr 08, 2024, across 1 active EPFO establishment.
GST
Lundbeck India has 10 GST registrations: 9 active and 1 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAACL6925E1ZH | Karnataka | Active | 01 Jul 2017 |
| 07AAACL6925E1ZN | Delhi | Active | 01 Jul 2017 |
| 18AAACL6925E1ZK | Assam | Active | 01 Jul 2017 |
| 19AAACL6925E1ZI | West Bengal | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Lundbeck India Private Limited, buy the company report.
Recent activity
Lundbeck India Private Limited has 11 board changes on record since 2004: 2 appointments and 9 cessations. The latest: Riyan Ahmed Khan ceased to be Additional Director on 29 Sep 2023.
2 earlier events are in the company report.
News
Frequently asked questions
Lundbeck India is currently "Under Liquidation" as per MCA records. The company's assets are being sold to settle outstanding debts owed to creditors. A company under liquidation may not have the legal capacity to fulfil new contracts, and creditors are prioritised in the distribution of proceeds. This is a high-risk status - caution is strongly advised.
Lundbeck India is a company under liquidation, formerly operating as a private limited company based in Bangalore, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 16 January 2002 and is registered under CIN U24231KA2002PTC029998. Caution is advised - the company may not have the legal capacity to fulfil new agreements.
Lundbeck India has 2 current directors:
- Morten Bryde Hansen - Director
- Riyan Ahmed Khan - Director
The latest financial statements of Lundbeck India on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Lundbeck India is U24231KA2002PTC029998. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Lundbeck India has 32 court cases on record: 25 filed by the company and 7 filed against it. 3 are pending. Most are in the district courts.
Lundbeck India was incorporated on 16 January 2002. It is registered with the Registrar of Companies, Bangalore.
The peers of Lundbeck India by revenue are 3C Pharmaceuticals Private Limited, Span Generics Private Limited, Getwell Nutraceuticals India Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Riyan Ahmed Khan ceased to be Additional Director on 29 Sep 2023. Riyan Ahmed Khan was appointed as Director on 11 Sep 2023. Prem Kumar Yogeshappa ceased to be Additional Director on 30 Sep 2022. Lundbeck India has 11 board changes on record in total.
Lundbeck India can be reached through the website lundbeck.com. Its registered office is in Bangalore, Karnataka, India.
The registered office of Lundbeck India is at 4C – 51540 4th Cross Hrbr Layout, Banasavadi, Bangalore, Karnataka, India – 560043.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
